These molecules are referred to as angioneurins, and are capable of both neural and vascular protection and repair.22 Top-quartile concentrations of ANG-1 most consistently predicted reduced ROP risk on all days, except day 1. This evidence concerns the gene ANGPT1 and retinopathy of prematurity.